Abstract:Background: Fampridine is the only drug that was approved by US Food and Drug Administration (FDA) for patients with multiple sclerosis to improve their movement and has exhibited a clinically significant improvement in gait function in subset of multiple sclerosis patients with Expanded Disability Status scale (ESDSS) from 4 to 7. Nevertheless, this drug has been reported to possess some adverse effects like seizure due to its pharmacological features. The aim of this study was to evaluate the incidence rate … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.